Immunosuppression by procarbazine. I. Sites of action of the drug and effect on adjuvant arthritis and circulating antibody responses.
D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000941:Antigens; D001168:Arthritis / Q000276:immunology*; D001565:Benzoates / Q000494:pharmacology*; D001853:Bone Marrow / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D007122:Immunoelectrophoresis; D007165:Immunosuppression Therapy; D008198:Lymph Nodes / Q000276:immunology / Q000473:pathology; D008297:Male; D009169:Mycobacterium tuberculosis / Q000276:immunology; D010047:Ovalbumin; D011344:Procarbazine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012756:Sheep; D013154:Spleen / Q000276:immunology / Q000473:pathology; D013950:Thymus Gland / Q000276:immunology / Q000473:pathology
D000276:Adjuvants, Immunologic; D000941:Antigens; D001565:Benzoates; D011344:Procarbazine; D010047:Ovalbumin